Eurycoma Longifolia
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.eurytest.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Eurycoma Longifolia
Aurinia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapies for patients afflicted with serious diseases that lack sufficient treatment options. The company is focused on the investigational drug voclosporin, aimed at treating lupus nephritis, a severe condition resulting from systemic lupus erythematosus. Aurinia's global development efforts target niche patient populations facing high unmet medical needs. Headquartered in Victoria, BC, Aurinia is at the forefront of innovating solutions for autoimmune-related kidney inflammation.Explore more
Popular SearchesEurycoma LongifoliaEurytestSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eurycoma Longifolia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Eurycoma Longifolia is spiking on competitors!
Product Launch: Get notified when Eurycoma Longifolia launches new products
Click to see if Eurycoma Longifolia had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Eurycoma Longifolia has new funding data
Website visits: Recent activity has been detected on your website
Check if Eurycoma Longifolia has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Eurycoma Longifolia
Eurycoma Longifolia, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Eurycoma Longifolia recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Eurycoma Longifolia
Compare insights from companies similar to Eurycoma Longifolia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Eurycoma Longifolia
<$5M
1-10
Private
-
-
N/A
Eurycoma Longifolia Tech Stack
A closer look at the technologies used by Eurycoma Longifolia
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eurycoma Longifolia
Sign Up For FreeTo access detailed company insights
Aurinia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapies for patients afflicted with serious diseases that lack sufficient treatment options. The company is focused on the investigational drug voclosporin, aimed at treating lupus nephritis, a severe condition resulting from sys... Read More
